IShares Nasdaq (UK) Profile

BTEC Etf   6.48  0.10  1.52%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
IShares Nasdaq is selling for under 6.48 as of the 2nd of March 2025; that is 1.52% down since the beginning of the trading day. The etf's lowest day price was 6.46. IShares Nasdaq has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 2nd of March 2025. Click here to learn more.
IShares Nasdaq is entity of United Kingdom. It is traded as Etf on LSE exchange. More on iShares Nasdaq Biotechnology

Moving against IShares Etf

  0.743ULS WisdomTree SP 500PairCorr
  0.51VILX SP 500 VIXPairCorr
  0.32LQQS WisdomTree NASDAQ 100PairCorr

IShares Etf Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. IShares Nasdaq's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding IShares Nasdaq or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationSector Equity Biotechnology (View all Sectors)
Updated At2nd of March 2025
iShares Nasdaq Biotechnology [BTEC] is traded in UK and was established null. The fund is listed under Sector Equity Biotechnology. iShares Nasdaq Biote currently have in assets under management (AUM). , while the total return for the last 3 years was 4.1%.
Check IShares Nasdaq Probability Of Bankruptcy

Top iShares Nasdaq Biotechnology Etf Constituents

KROSKeros TherapeuticsStockHealth Care
BBIOBridgeBio PharmaStockHealth Care
OMEROmerosStockHealth Care
VIRVir BiotechnologyStockHealth Care
ETNB89bio IncStockHealth Care
LXRXLexicon PharmaceuticalsStockHealth Care
ITCIIntracellular ThStockHealth Care
CMPSCompass Pathways PlcStockHealth Care
More Details

iShares Nasdaq Biote Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IShares Nasdaq. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

iShares Nasdaq Biote Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. iShares Nasdaq Biote Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe IShares Nasdaq price patterns.

IShares Nasdaq Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in IShares Nasdaq without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Investing Opportunities Now

   

Investing Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Other Information on Investing in IShares Etf

IShares Nasdaq financial ratios help investors to determine whether IShares Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IShares with respect to the benefits of owning IShares Nasdaq security.